🇺🇸 Xylocaine with Epinephrine in United States

367 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Drug Ineffective — 120 reports (32.7%)
  2. Therapeutic Product Effect Decreased — 65 reports (17.71%)
  3. Off Label Use — 38 reports (10.35%)
  4. Bradycardia — 34 reports (9.26%)
  5. Pain — 26 reports (7.08%)
  6. Hypotension — 22 reports (5.99%)
  7. Injection Site Pain — 20 reports (5.45%)
  8. Haemorrhage — 16 reports (4.36%)
  9. Cardiac Arrest — 13 reports (3.54%)
  10. Cardiogenic Shock — 13 reports (3.54%)

Source database →

Other Anesthesia approved in United States

Frequently asked questions

Is Xylocaine with Epinephrine approved in United States?

Xylocaine with Epinephrine does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for Xylocaine with Epinephrine in United States?

Vrije Universiteit Brussel is the originator. The local marketing authorisation holder may differ — check the official source linked above.